Not Yet Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia
NCT07693777
- Conditions
- Digestive System Diseases, Dyslipidemias, Fatty Liver, +10 more
- Locations
-
- Zhongshan Hospital Shanghai, China